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Abstract
Study objectives To study the pattern of upper airway collapse in patients with CPAP failure by performing DISE while
administering CPAP therapy and to determine the reason for CPAP failure accordingly.
Methods This observational retrospective study comprised 30 patients diagnosed with OSA and CPAP failure, who underwent
DISE while administering CPAP therapy. During DISE, the upper airway was assessed with and without CPAP therapy using the
VOTE classification. Additionally, a jaw thrust maneuver was performed, in order to mimic the effect of an additional mandibular
advancement device (MAD) in combination with CPAP therapy. Consequently, the outcome of DISE was translated into a
clinically relevant categorization.
Results Eleven patients (37%) had a persistent anteroposterior (AP) collapse, including a collapse at velum, tongue base, or
epiglottis level and multilevel collapse. Eight patients (27%) had a floppy epiglottis. Five patients (17%) had a persistent
complete concentric collapse (CCC) and three patients had a persistent laryngeal collapse (10%). In three patients (10%), no
airway collapse was found after CPAP administration.
Conclusions Based on the results of the reported study, in most cases, the potential cause of CPAP failure can be determined by
this new diagnostic method. Consequently, suggestions can be made for additional therapy.
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Introduction
Obstructive sleep apnea (OSA) is a sleep-related breathing
disorder characterized by repetitive partial or complete
pharyngeal collapse causing reduction (hypopnea) or cessa-
tion (apnea) of airflow resulting in hypoxemia associated with
sleep fragmentation, daytime sleepiness, and possible cardio-
vascular and metabolic dysfunction [1, 2]. OSA is a common
condition globally. Population-based studies show that ap-
proximately 4% of men and 2% of women are affected by
OSA [3]. In a more recent study, prevalence showed to be
even higher with approximately 23% of women and 50% of
men being affected [4]. Continuous positive airway pressure
(CPAP) is unequivocally regarded as the gold standard treat-
ment and often the treatment of first choice in patients with
severe OSA. CPAPworks as pneumatic splint preventing noc-
turnal collapse of the upper airway, reducing the apnea-
hypopnea index (AHI), and improving the quality of sleep
[5, 6]. However, its effectiveness can be limited by adherence
and tolerance, insufficient decrease in AHI, and limited im-
provement of symptoms [7]. In the present literature, the term
CPAP failure is being used and interpreted in various ways
including both poor tolerance and insufficient decrease in
AHI. Recently, in order to create an unambiguous definition,
a new nomenclature was proposed: (1) CPAP failure upon
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efficacy in case of an insufficient decrease in residual AHI
above 5 apneas per hour, (2) CPAP failure to diminish symp-
toms when symptoms remain in spite of an adequate decrease
in AHI, (3) CPAP intolerance in case of side effects and/or
psychological reluctance, and (4) CPAP non-adherence in
case of incorrect or insufficient use of CPAP [2]. Multiple
studies have been performed to identify factors that influence
or predict CPAP intolerance or non-adherence [7–10].
However, not much is known about predictors for CPAP fail-
ure upon efficacy (hereinafter referred to as “CPAP failure”).
Drug-induced sleep endoscopy (DISE), first described
in 1991 by Croft and Pringle, is a diagnostic evaluation
tool for the degree, level(s), and pattern of upper airway
obstruction in patients with OSA [11, 12]. DISE is often
performed in order to consider other treatment options like
surgical procedures, oral appliance treatment (including
mandibular advancement devices), and upper airway stim-
ulation. Recently, various studies have shown that DISE
can be successful for CPAP titration; characteristics of air-
way collapse were evaluated as possible predictors for
CPAP titration level [13–15]. However, to date, there are
no studies that focus on evaluating the pattern of upper
airway collapse while administering CPAP therapy to de-
termine the cause of CPAP failure. In this paper, we give a
detailed overview of our findings during DISE and identi-
fy the cause of CPAP failure individually. Consequently,
suggestions will be made for additional therapy.
Material and methods
Study design and population
This study was designed as a retrospective, single-center
descriptive cohort study including 30 consecutive patients
diagnosed with CPAP failure due to an insufficient de-
crease in AHI above 5 apneas per hour. All patients were
previously diagnosed with OSA which was either con-
firmed by polysomnography (PSG) or respiratory
polygraphy (home sleep apnea test or PG) and were ini-
tially treated with CPAP. During follow-up, all patients
experienced persistent OSA-related complaints and repeat-
edly measured an AHI above 5 apneas per hour despite
intensive support and additional CPAP titration. Patients
were extensively discussed in the multidisciplinary sleep
team, composed of ENT-surgeons, neurologists, oral and
maxillofacial surgeons, and pulmonologists and were di-
agnosed with CPAP failure. Drug-induced sleep endosco-
py with and without administering CPAP therapy was car-
ried out in order to identify the cause of CPAP failure.
Subjects with and without previous nasal and/or pharyn-
geal surgery were included.
Drug-induced sleep endoscopy
Drug-induced sleep endoscopy was carried out in a quiet op-
erating room with dimmed lights. All procedures were carried
out by the same experienced ENT-surgeon (MC) with an an-
esthesiologist to manage sedation. Sleep was induced by an
initial bolus of 1 mg/kg propofol followed by manual titration
of propofol. The optimal depth of sedation was reached when
the patient began to snore and/or no awakening from vocal or
tactile stimuli was achieved. Once a proper level of sedation
was approached, the upper airway was thoroughly observed
by flexible fiberoptic laryngoscopy. The upper airway was
assessed in supine position using the VOTE classification ear-
lier described by Kezirian et al. (Table 1) [16, 17]. This clas-
sification system is commonly used to assess levels and struc-
tures that may contribute to upper airway obstruction, namely
velum (V), oropharynx (O), tongue base (T), and epiglottis
(E). For each anatomical level, the configuration
(anteroposterior, lateral, or concentric) and severity (no ob-
struction, partial obstruction, or complete obstruction) of the
upper airway collapse were described. Subsequently, an
adapted CPAP mask—allowing an endoscope to enter the
nose, while permitting to increase CPAP pressures without
air leakage—was adjusted (Fig. 1). After the flexible laryngo-
scope was introduced into the nasal cavity via the adapted
CPAP mask, CPAP therapy was started at a pressure of 6 cm
H2O and gradually enhanced until the potential obstruction
was discontinued or a pressure of 16 cm H2O was reached.
Again, the upper airway was assessed by using the VOTE
classification while administering CPAP therapy.
Additionally, a jaw thrust maneuver was performed, in order
to mimic the effect of mandibular advancement device
(MAD) in combination with CPAP therapy. The jaw thrust
maneuver was called positive if the obstruction was
discontinued on all levels. The jaw thrust maneuver was called
negative if the obstruction was still present on one (or more)
levels.
Statistical analysis
The statistical analysis was performed by using Statistical
Package for Social Studies (IBM SPSS Statistics version 24
for Windows, New York, NY, USA). Descriptive statistics
were accomplished to create the baseline characteristics.
Continuous variables are presented as means with standard
deviations. Categorical variables are presented as frequencies
with percentages. Comparisons between groups were per-
formed using chi-square test for categorical variables,
Student’s t test, and univariate analysis of variance
(ANOVA) for continuous variables. For all analyses, a two-
tailed p value of < 0.05 was considered statistically
significant.
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Results
Baseline characteristics
The study population consisted of 30 patients. Patients were
predominantly men (80%), with a mean age of 56.8 ±
13.0 years and a mean BMI of 28.6 ± 4.5 kg/m2. Previous
nasal/or pharyngeal surgery was performed in 13 patients
(43%). In two patients (7%), uvulopalatopharyngoplasty was
performed as previous OSA treatment. Nine patients (30%)
underwent previous tonsillectomy. However, in all patients,
the tonsillectomy was not OSA related. Two patients (7%)
underwent previous closure of a cleft palate. The mean pre-
treatment AHI was 42.1 ± 22.4 (7.0–96.0); the mean central
breathing events per hour were 4.4 ± 6.9. The mean AHI with
CPAP therapy was 26.0 ± 16.3 (5.7–69.4) (Table 2). The ini-
tial AHI and AHI with CPAP therapy are presented for each
subject individually in Fig. 2. A significant decrease in AHI
after CPAP therapy with an average of 16.1 events per hour
was found (95% CI, 10.0–22.3; p < 0.0005). However, all
patients experienced persistent OSA-related complaints and
measured a residual AHI above 5 apneas per hour.
DISE analysis
All patients underwent DISE, while CPAP was administered,
during which no complications occurred. Table 3 shows DISE
findings while administering CPAP therapy utilizing the
VOTE classification. Figure 3 shows the distribution of the
main outcomes. Eleven patients (37%) had a persistent
anteroposterior (AP) collapse, including a collapse at velum,
tongue base, or epiglottis level and amultilevel collapse. Eight
patients (27%) had a floppy epiglottis. Five patients (17%)
had a persistent complete concentric collapse (CCC) and three
Fig. 1 Front and side view of the
adapted CPAP mask. The adapted
CPAP mask has a small opening
in front allowing an endoscope to
enter the nose, while permitting to
increase CPAP pressures without
air leakage
Table 1 VOTE classification. At each level, the degree and
configuration of obstruction should be classified. In each individual,
only one degree and configuration of obstruction can be scored on each
level. Open boxes reflect the potential configuration that can be visualized
related to a specific structure. Shaded boxes reflect that a specific
structure-configuration cannot be seen (for example, oropharynx lateral
walls in an anteroposterior direction). The degree of obstruction is clas-
sified as: 0, no obstruction (no vibration, collapse < 50%); 1, partial ob-
struction (vibration, collapse 50–75%); 2, complete obstruction (collapse
> 75%); x, not assessable
Level Direction
Anteroposterior Lateral Concentric
Velum
Oropharynx
Tongue 
base
Epiglottis
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patients showed a laryngeal collapse (10%). In three patients
(10%), no airway collapse was found after CPAP administra-
tion; in two patients, air leakage via the mouth was objectified,
when closing the mouth CPAP therapy was effective. While
administering CPAP therapy, a jaw thrust maneuver was per-
formed. The obstruction was discontinued on all levels in 22
cases, two cases showed a persistent obstruction on one (or
more) levels. In the three patients who did not have any upper
airway collapse while administering CPAP, the jaw thrust ma-
neuver was not performed. In the remaining three patients a
jaw thrust maneuver was not reported.
The mean age, BMI, and AHI with CPAP therapy were
compared between the different DISE outcomes. All variables
were statistically significantly different for the different out-
comes of DISE (p = 0.060, p = 0.019, and p = 0.017
respectively). An LSD post hoc test was done to specify be-
tween which groups the underlying difference was statistically
significant. Firstly, patients with a persistent CCC were sig-
nificantly younger than patients with a floppy epiglottis (p =
0.043) or a laryngeal collapse (p = 0.027). Patients with a la-
ryngeal collapse were significantly older than patients encoun-
tering mask problems (p = 0.031). Secondly, patients with a
persistent CCC had a significantly higher BMI than patients
with a persistent AP collapse (p = 0.011) or floppy epiglottis
(p = 0.002). Lastly, comparing the groups based on their mean
AHI with CPAP therapy, we found that patients with a persis-
tent AP collapse had a significantly lower AHI than patients
with a persistent CCC (p = 0.015) or laryngeal collapse (p =
0.026). Patients with mask problems had a significantly lower
AHI compared to patients with persistent CCC (p = 0.007) or
laryngeal collapse (p = 0.010).
Treatment
The distribution of different treatment options advised on ac-
count of the DISE outcome is shown in Fig. 4. In 21 of the 22
patients with a positive effect of the jaw thrust maneuver, either
a MAD or a MAD combined with CPAP therapy was advised.
In the other patient, a therapy including aMADwas impossible
due to an edentate mandible. In four patients, a different CPAP
mask was advised. One patient was advised to lose weight. In
four patients, other treatment options were advised, including
soft palate surgery, referral to a plastic surgeon because of
CPAP failure due to an earlier unsuccessful operation of a cleft
palate, and tracheotomy because of CPAP failure due to a la-
ryngeal collapse at the level of the arytenoid cartilages.
Fig. 2 Bar graph showing the pretreatment AHI and AHI with CPAP therapy. Pretreatment AHI is presented in darker blue, AHI with CPAP therapy is
presented in light blue. The horizontal black line indicates an AHI of 5 events/h
Table 2 Baseline characteristics of included patients with CPAP failure
Patient characteristics Mean ± SD Range
Mena 24 (80%) –
Ageb 56.8 ± 13.0 30–78
BMIc 28.6 ± 4.5 17.9–38.6
Pretreatment AHId 42.1 ± 22.4 7.0–96.0
AHI with CPAP therapy 26.0 ± 16.3 5.7–69.4
SD, standard deviation; BMI, body mass index; AHI, apnea-hypopnea
index; CPAP, continuous positive airway pressure
a Gender is expressed as number and percentage (%) instead of mean ±
SD
bAge in years
c BMI in kg/m2
dAHI in apneas and hypopneas per hour
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Table 3 Overview of the distribution of the levels and pattern of upper airway collapse during DISE with CPAP
Level Direction
AP Lateral Concentric
None Partia
l
Complet
e
None Partia
l
Complet
e
Non
e
Partia
l
Complet
e
Velum 46.7
%
6.7% 30.0% - - - - - 16.7 %
Oropharyn
x
100
%
- - - - -
Tongue 
base
76.7
%
13.3 
%
10.0%
Epiglottis 46.7
%
10.0
%
43.3% - - -
Fig. 3 Distribution of outcome of the examination during DISE when CPAP therapy is administered
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Discussion
In this study, we were able to observe the effect of CPAP therapy
on the pattern of upper airway collapse. Our findings show that a
possible reason for CPAP failure can predominantly be identified.
Previously, studies have been conducted to expand the utilization
of DISE for CPAP titration and to evaluate possible predictors for
CPAP titration level [14, 15]. Additionally, studies have been con-
ducted to evaluate the upper airway collapse in patientswithCPAP
failure [18, 19]. However, to date there are no studies that focus on
evaluating the pattern of upper airway obstruction while adminis-
tering CPAP therapy. Acknowledging this problem, we believe
that our results are highly relevant to the field. To the best of our
knowledge, this is the first study to investigate the role of DISE
while administering CPAP therapy as a method to clarify possible
mechanisms leading to CPAP failure and to address further treat-
ment options. Our results may extent the utilization of DISE as a
new diagnostic method in patients with OSA and CPAP failure.
In 2017, Torre et al. have shown that CPAP has a greater
impact on the lateral walls of the oropharynx than it has on the
velum, tongue base, or epiglottis [15]. A result that is endorsed
by a study of Schwab et al. [20]. Our findings underline these
observations since persistent lateral collapse of the orophar-
ynx was not observed in our study. Another interesting finding
is that some patients who were shown to have a floppy epi-
glottis during CPAP treatment were satisfied with this treat-
ment for many years. This raises the question if this phenom-
enon might be instigated by long-term CPAP usage.
Furthermore, in the present study, persistent CCC was associ-
ated with a higher BMI. The same observations were previ-
ously made by Hasselbacher et al. and Steffen et al. [19, 21].
Additionally, patients with persistent CCC or laryngeal col-
lapse had a higher AHI with CPAP therapy than patients with
AP collapse. Previous authors have shown similar results;
patients suffering from CCC have a significantly higher initial
AHI [18, 19, 21]. In a recent study that focuses on DISE as a
selection tool for upper airway stimulation by Vanderveken
et al., it is stated that the absence of CCC can predict success
of upper airway stimulation [22]. Our results indicate that,
possibly, CCC is also a negative predictor for CPAP therapy.
Fig. 4 Distribution of the different treatment options advised on account of the DISE outcome
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However, the sample size in our study was limited, so further
investigations with larger sample sizes need to be conducted
in the future to validate these results.
Limitations
This study has several limitations. It is obvious that assess-
ment of the upper airway during DISE is based on subjective
findings and therefore, prone to experience bias. However,
previous studies have shown a moderate to substantial
interrater reliability depending on the experience of the sur-
geon [23, 24]. Furthermore, the degree of anesthetic depth and
body position can alter the upper airway collapse [25, 26].
Opponents of DISE argue that pharmacologically induced
sleep, e.g., by propofol as in this study, is characterized by
changing sleep patterns. Conversely, Rabelo et al. have shown
that the AHI and other respiratory parameters remain unaffect-
ed [27]. It is nevertheless important not to oversedate [25].
Patients respond differently to propofol; therefore, it is
stressed that the technique to elicit sleep must be standardized
rather than to establish a universal concentration for all pa-
tients [27]. In this context, we used a consistent method of
sedation in all patients by administering an initial bolus of
1 mg/kg. However, after the initial bolus, titration of propofol
was administered manually until the patient began to snore
and/or no awakening from vocal or tactile stimuli was
achieved. In order to aim for a standardized technique, in
future measuring sedation depth and the use of target-
controlled infusion pumps should be considered. It may also
be discussed that the jaw thrust maneuver to mimic the effect
of a MAD is a very imprecise maneuver as it lacks reproduc-
ibility and standardization. However, despite its limitations,
performing a jaw thrust maneuver can easily and routinely
be implemented during DISE and might improve patient se-
lection for (additional) MAD treatment [28]. Undoubtedly, the
retrospective nature and the small sample size of this study are
the limitating factors. Testing for possible associations be-
tween the outcome of DISE and the befitting treatment was
not applicable due to this small sample size. Additionally, the
correlations found between DISE results and age, BMI, and
AHI with CPAP therapy are based on a small sample size and
therefore only tentative conclusions can be drawn. Studies
with a larger sample size need to be conducted in the future
in order to validate these results.
Conclusion
The results of this study provide important insight into the
possible patterns of upper airway obstruction while adminis-
tering CPAP therapy. In most cases, a possible cause of CPAP
failure can be identified individually. Furthermore, we dem-
onstrate that determining the reason of CPAP failure can lead
towards new suggestions for treatment options in addition to/
instead of CPAP therapy, including surgery or an MAD.
However, further analysis of the association between outcome
of DISE and treatment options and analysis of the treatment
outcome needs to be conducted in future studies.
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